191 related articles for article (PubMed ID: 7037348)
21. Diabetics treated with continuous subcutaneous insulin infusion pumps.
Foley-Nolan D; Foley-Nolan A; Temperley D; Devlin J
Ir Med J; 1989 Dec; 82(4):159-60. PubMed ID: 2516015
[TBL] [Abstract][Full Text] [Related]
22. Intrapartum management of insulin-dependent diabetes mellitus (IDDM) gestants. A comparative study of constant intravenous insulin infusion and continuous subcutaneous insulin infusion pump (CSIIP).
Feldberg D; Dicker D; Samuel N; Peleg D; Karp M; Goldman JA
Acta Obstet Gynecol Scand; 1988; 67(4):333-8. PubMed ID: 3051881
[TBL] [Abstract][Full Text] [Related]
23. No sign of amyloidosis in pump-treated diabetics.
Regal H; Koivisto VA; Maury CP; Irsigler K
Diabetes Res; 1988 Aug; 8(4):195-9. PubMed ID: 3069282
[TBL] [Abstract][Full Text] [Related]
24. [Intensified insulin therapy by multiple injections or by pump].
Pernet A
Schweiz Med Wochenschr; 1986 Jan; 116(3):77-82. PubMed ID: 3511525
[TBL] [Abstract][Full Text] [Related]
25. Control of diabetes through a subcutaneous peritoneal access device (SPAD) in patients with resistance to subcutaneously injected insulin.
Dandona P; Fonseca V; Fernando O; Menon RK; Weerakoon J; Kurtz A; Stephen R
Diabetes Res; 1987 May; 5(1):47-9. PubMed ID: 3304785
[TBL] [Abstract][Full Text] [Related]
26. Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes.
Hoogma RP; Schumicki D
Horm Metab Res; 2006 Jun; 38(6):429-33. PubMed ID: 16823727
[TBL] [Abstract][Full Text] [Related]
27. A comparison of premeal subcutaneous insulin infusion and injection in type I diabetic patients under continuous basal subcutaneous insulin delivery.
Navascués I; Kerner W; Pfeiffer EF
Life Support Syst; 1985; 3(3):263-7. PubMed ID: 3900596
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of resistance to subcutaneous insulin with implanted insulin infusion pumps].
Löchli S; Campbell I; Dorenboos H; Paterson KR; Devlin JG; Hagmüller G; Irsigler K
Dtsch Med Wochenschr; 1988 Sep; 113(36):1390-3. PubMed ID: 3138098
[TBL] [Abstract][Full Text] [Related]
29. Preprogrammed insulin infusion with a portable pump system.
Irsigler K; Kritz H; Kaspar L; Brändle J; Koller W; Franetzki M
Horm Metab Res Suppl; 1979; (8):193-7. PubMed ID: 119699
[TBL] [Abstract][Full Text] [Related]
30. Long-term improvement in metabolic control of unstable type I diabetes by s.c. insulin injection patterns based on the dose profiles required by bed-side artificial beta-cell.
Bombor H; Bruns W; Ratzmann KP; Jutzi E; Albrecht G; Michaelis D; Fischer U
Exp Clin Endocrinol; 1984 Apr; 83(2):143-51. PubMed ID: 6373316
[TBL] [Abstract][Full Text] [Related]
31. SHBG (sex hormone binding globulin) levels in insulin dependent diabetic patients according to the route of insulin administration.
Lassmann-Vague V; Raccah D; Pugeat M; Bautrant D; Belicar P; Vague P
Horm Metab Res; 1994 Sep; 26(9):436-7. PubMed ID: 7835829
[No Abstract] [Full Text] [Related]
32. Insulin therapy on the peritoneal route: effects on glucose control in experimental insulin dependent diabetes.
Fischer U; Fritze K; Freyse EJ
Exp Clin Endocrinol; 1990 Feb; 95(1):11-21. PubMed ID: 2185935
[TBL] [Abstract][Full Text] [Related]
33. [Insulin-induced edema in adolescents with type 1 diabetes mellitus].
Saule H
Dtsch Med Wochenschr; 1991 Aug; 116(31-32):1191-4. PubMed ID: 1860423
[TBL] [Abstract][Full Text] [Related]
34. Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin.
Freidenberg GR; White N; Cataland S; O'Dorisio TM; Sotos JF; Santiago JV
N Engl J Med; 1981 Aug; 305(7):363-8. PubMed ID: 7019707
[TBL] [Abstract][Full Text] [Related]
35. [Blood-sugar-controlled insulin infusion systems for rapid adjustment of insulin-dependent diabetics (author's transl)].
Beyer J; Becker G; Schulz G; Gaberle E; Wolf E; Hassinger W; Cordes U
Dtsch Med Wochenschr; 1981 Dec; 106(49):1644-9. PubMed ID: 7030687
[TBL] [Abstract][Full Text] [Related]
36. [Short-term subcutaneous infusion of insulin using a portable insulin pump in the treatment of diabetes mellitus].
Krzymień J; Szymerska E; Bak M; Regulski M; Tracz M
Pol Arch Med Wewn; 1989 Apr; 81(4):214-22. PubMed ID: 2626347
[TBL] [Abstract][Full Text] [Related]
37. Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: comparison with intravenous and subcutaneous routes.
Selam JL; Slingeneyer A; Hedon B; Mares P; Beraud JJ; Mirouze J
Diabetes Care; 1983; 6(2):105-11. PubMed ID: 6406198
[TBL] [Abstract][Full Text] [Related]
38. [Continuous subcutaneous insulin infusion with portable pumps].
Radermecker RP; Hermans MP; Legrand DA; Scheen AJ
Rev Med Liege; 2005; 60(5-6):329-34. PubMed ID: 16035289
[TBL] [Abstract][Full Text] [Related]
39. [Characterisation of activity of a biphasic monocomponent insulin (author's transl)].
Neubauer M; Althoff PH; Schnabel O; Genrich V; Schöffling K
Dtsch Med Wochenschr; 1979 Mar; 104(11):384-90. PubMed ID: 421667
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of extremely brittle, insulin-dependent diabetes with a novel subcutaneous insulin pump regimen.
Nathan DM
Diabetes Care; 1982; 5(2):105-10. PubMed ID: 6821487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
